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OBSTETRICSSeverity of influenza and noninfluenza acute
respiratory illness among pregnant women,
2010e2012
Leslie Z. Sokolow, MS, MPH; Allison L. Naleway, PhD; De-Kun Li, MD, PhD;
Pat Shifflett, RN, MS; Sue Reynolds, MS, MPH; Michelle L. Henninger, PhD;
Jeannette R. Ferber, MPH; Roxana Odouli, MSPH; Stephanie A. Irving, MHS;
Mark G. Thompson, PhD; for the Pregnancy and Influenza Project WorkgroupOBJECTIVE: The objective of the study was to identify characteristics feverishness (18% vs 5%; P < .001), myalgia (28% vs 14%;
of influenza illness contrasted with noninfluenza acute respiratory
illness (ARI) in pregnant women.
STUDY DESIGN: ARI among pregnant women was identified through
daily surveillance during 2 influenza seasons (2010-2012). Within
8 days of illness onset, nasopharyngeal swabs were collected, and
an interview was conducted for symptoms and other characteristics.
A follow-up telephone interview was conducted 1-2 weeks later, and
medical records were extracted. Severity of illness was evaluated
by self-assessment of 12 illness symptoms, subjective ratings of
overall impairment, highest reported temperature, illness duration,
and medical utilization.
RESULTS: Of 292 pregnant women with ARI, 100 tested positive for
influenza viruses. Women with influenza illnesses reported higher
symptom severity than those with noninfluenza ARI (median score, 18
vs 16 of 36; P< .05) and were more likely to report severe subjectiveFrom the Inﬂuenza Division, Centers for Disease Control and Prevention (Ms
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Open access under CC BY-NC-ND license.P < .005), cough (46% vs 30%; P < .01), and chills (25% vs 13%;
P < .01). More influenza illnesses were associated with fever greater
than 38.9C (20% vs 5%; P< .001) and higher subjective impairment
(mean score, 5.9 vs 4.8; P < .001). Differences in overall symptom
severity, fever, cough, chills, early health careeseeking behavior, and
impairment remained significant in multivariate models after adjusting
for study site, season, age, vaccination status, and number of days
since illness onset.
CONCLUSION: Influenza had a greater negative impact on pregnant
women than noninfluenza ARIs, as indicated by symptom severity
and greater likelihood of elevated temperature. These results highlight
the importance of preventing and treating influenza illnesses in
pregnant women.
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compared with noninﬂuenza ARI during
2 inﬂuenza seasons. Although the num-
ber of conﬁrmed inﬂuenza cases was
limited, we conducted exploratory ana-
lyses to assess whether inﬂuenza illness
severity was higher among the women
with comorbid conditions or in their
third trimester and whether vaccination
with a seasonal inﬂuenza vaccine was
associated with less severe illness among
those women with vaccine failure.
MATERIALS AND METHODS
Recruitment and eligibility
The study methodology7 and recruit-
ment of the study participants have been
described in detail previously.6 Eligible
participants were Kaiser Permanente
members who made at least 1 prenatal
visit in the Portland, OR (Kaiser Per-
manente Northwest), or San Francisco,
CA, metropolitan areas (Kaiser Perma-
nente Northern California) during the
study period, had an expected delivery
date after Nov. 15, 2010, and were at least
16 years of age for Kaiser Permanente
Northwest or at least 18 years of age
for Kaiser Permanente Northern Cali-
fornia. The study instruments, pro-
cedures, and written consent documents
were approved by the institutional re-
view boards at both sites.
Surveillance
The inﬂuenza season was deﬁned by
the regional/state health department
and the Centers for Disease Control
and Prevention inﬂuenza surveillance
data. Thresholds for the beginning and
end of the season were deﬁned a priori
at each site. During both study seasons,
we identiﬁed potential ARIs using
daily surveillance of electronic medical
records (EMRs) for medically attend-
ed acute respiratory illness using Inter-
national Classiﬁcation of Diseases,
ninth revision (ICD-9) codes 460-466,
480-488, and 490-491.
The women were contacted by tele-
phone, screened for eligibility, and
asked to provide written consent for
study participation. Inclusion criteria
included enrollment in the health planfor the study season and completion of
the enrollment interview.
During the ﬁrst season, weekly
Internet- or telephone-based surveil-
lance monitored the occurrence of non-
medically attended ARI among a pro-
spective cohort of participants at both
sites.7 First-season participants were
encouraged to contact staff directly if
they became ill; those who did not
complete a weekly surveillance report
received a reminder e-mail or telephone
call to assess current ARI status. For both
seasons, nasopharyngeal swab speci-
mens were collected at the homes of
women with self-reported cough and
fever, feverishness, or chills within 8 days
of illness onset.
Participant characteristics
Sociodemographic characteristics were
assessed during an enrollment inter-
view. Health status prior to illness was
assessed with 3 measures. First, overall
self-rated health was assessed using a
standard question on current health
(poor, fair, good, very good, or excellent)
on the enrollment interview.8 Second,
we identiﬁed high-risk comorbidities
associated with an increased risk of
inﬂuenza complications by the presence,
during 2 or more visits over 1 year prior
to conception, of the following condi-
tions: cancer, diabetes mellitus, neuro-
logical disorders, chronic pulmonary
disease, chronic cardiac disease, immu-
nosuppressive disorders, and chronic
renal disease.9 Third, pregnancy com-
plications, from conception to start of
surveillance, were identiﬁed from EMRs,
using ICD-9 codes related to adverse
pregnancy outcomes. All ICD-9 codes
are available upon request. Obesity was
deﬁned by body mass index, calculated
using self-reported prepregnancy weight
and height.
Illness characteristics
Illness characteristics were assessed
during an illness episode interview at
specimen collection and again at a
follow-up telephone contact approxi-
mately 8 days later. In the ﬁrst season,
participants who were still ill were called
again approximately 14 days after the
original illness interview.FEBRUARY 2015 AmeriWe assessed 5 indicators of illness
severity. First, participants rated the
presence and severity of 12 symptoms,
using a 4 point scale (0, absent; 1, mild;
2, moderate; and 3, severe). Ten partici-
pants who initially reported a cough at
the screening interview described a
cough as absent during their illness in-
terview; in these instances, responses
were recoded as 1 (mild). All symptom
ratings were summed to form a 12 sym-
ptom severity score, ranging from 1 (a
single mild symptom) to 36 (all symp-
toms severe), as described previously.10
Second, participants assessed the
overall subjective severity of illness
from 0 (normal health) to 9 (worst
possible health) and the extent of illness
impairment from 0 (able to perform
usual activities) to 9 (unable to do so), as
described previously.11
Third, we examined febrile severity
using the subjective severity of feverish-
ness (mild, moderate, or severe) and the
highest temperature recorded using any
of the following: EMR vital signs (if
the illness was medically attended), self-
reported highest temperature at either
the illness interview or 8e14 day follow-
up interview(s), or measured tempera-
ture by visiting study staff. Severe fever
was deﬁned as 38.9C, which represents
the threshold for assessing teratogenic
exposure in the fetus.
Fourth, we calculated illness du-
ration by subtracting the illness onset
date (determined from screening or
illness episode interview) from the date
of symptom resolution as indicated
in follow-up interviews. Seventy-eight
women (53 noninﬂuenza and 25 inﬂu-
enza) who either were unable to recall
a recovery date or had not yet re-
covered when the follow-up interview
occurred were excluded from our anal-
ysis of illness duration.
Fifth, we examined medical utilization
and self-care as indicatedby the following:
(1) any or more than 1 medical visit, (2)
any illness-associated hospitalization, (3)
seeking health care within 2 days of onset,
and (4)use of antibiotic, over-the-counter
(OTC), or antiviral medications associ-
ated with the ARI as reﬂected in an EMR-
conﬁrmed prescription or self-reported
use of a medication during the illness.can Journal of Obstetrics& Gynecology 202.e2
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Inﬂuenza vaccination status was
documented by EMRs if available or
by self-report if the participant was
vaccinated outside the health plan;
14 (5%) were based on self-report.
Participants who received seasonal
inﬂuenza vaccine 14 days or more
before illness onset were considered
vaccinated.
Laboratory methods
Respiratory specimens were collected
using nasopharyngeal swabs and stored
with transport medium in cryovials at
e70C before overnight shipping on dry
ice to the Marshﬁeld Clinic Research
Foundation laboratory (Marshﬁeld,
WI). Real-time reverse transcription
polymerase chain reaction (RT-PCR)
was performed using primer, probes,
reagents, and proﬁciency panel pro-
vided by the Centers for Disease Control
and Prevention Inﬂuenza Division
(more information at http://www.cdc.
gov/ﬂu/clsis). We excluded participants
whose specimens were collected moreFIGURE 1
Flow chart showing enrollment and e
ARI, acute respiratory illness; S1, season 1 (2010-2011); S2, seaso
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202.e3 American Journal of Obstetrics& Gynecolthan 8 days after illness onset from our
analysis.
Statistical methods
Six participants (2%) reported having
had more than 1 ARI episode during the
study period. For women testing positive
for an inﬂuenza virus, we used the illness
episode associated with the positive
result. For inﬂuenza-negative partici-
pants, we used their ﬁrst illness episode.
We compared participant character-
istics using the 2-tailed c2 or Fisher
exact test for categorical outcomes and
the Student t test for continuous vari-
ables. Statistically signiﬁcant (P < .05)
bivariate associations between inﬂuenza
and severity indicators were followed
by multivariate analyses (logistic re-
gression) to determine whether the
observed association persisted after
adjusting for site, season, age, days since
illness onset, and vaccination status;
results were expressed as adjusted odds
ratios with accompanying 95% conﬁ-
dence intervals. Analyses were con-
ducted using IBM SPSS (IBM, Armonk,xclusions for each study season
n 2 (2011-2012).
ynecol 2015.
ogy FEBRUARY 2015NY) and SAS 9.3 (SAS Institute, Cary,
NC) software.
RESULTS
Participant and illness
characteristics
Of 1873 participants enrolled in the
study, 353 pregnant women with 1 or
more ARIs (107 inﬂuenza and 246 non-
inﬂuenza) were identiﬁed over 2 consec-
utive seasons. Seven inﬂuenza illnesses
and 54 noninﬂuenza ARIs were excluded
because illness onsets were outside the
surveillance season or after delivery or
because specimens were collected more
than 8 days after illness onset.
After limiting the analyses to a single
illness episode per participant, we
included 292 illnesses: 100 inﬂuenza-
positive and 192 noninﬂuenza ARIs
(Figure 1). All of these illnesses were
medically attended, with the exception
of 27 ARIs (8 inﬂuenza and 19 non-
inﬂuenza illnesses) identiﬁed as part of
cohort surveillance during the ﬁrst sea-
son. All 3 inﬂuenza viruses circulated in
both seasons, although the median onset
date of inﬂuenza illnesses was 3 weeks
later in the second season (Feb. 22, 2011,
vs March 14, 2012; Appendix; Supple-
mental Figure).
Inﬂuenza positivity differed by days
since illness onset when the specimen
was collected (P < .05); this difference
was due to the relatively high inﬂuenza
positivity on day 1 since illness onset
(65%) compared with a varying range of
positivity noted on days 2-8 (26-44%).
Combining both seasons, 45 women had
RT-PCReconﬁrmed A(H1N1)pdm09
virus infections, 33 had A(H3N2), 1 had
an unsubtyped A virus, and 21 had
inﬂuenza B virus infections.
Participant characteristics are pre-
sented in Table 1. About half of partici-
pants (54%) were white non-Hispanics,
and 24% were Hispanics. At the time of
illness onset, the mean age was 30.7
years, and most women were in their
second (44%) or third (41%) trimester.
Women with inﬂuenza illnesses were
similar to those with noninﬂuenza ARIs
on most sociodemographic and health
indicators, with 2 exceptions: women
with inﬂuenza were less likely to have
a preexisting comorbidity (17% vs 30%;
TABLE 1
Sociodemographic characteristics of pregnant women with influenza vs noninfluenza ARIs
Characteristics
Noninfluenza ARI
(n[ 192)
Influenza
(n[ 100) P value Total (n[ 292)
Study site
Kaiser Permanente Northern California 111 (58) 69 (69) NS 180 (62)
Kaiser Permanente Northwest 81 (42) 31 (31) 112 (38)
Study season
2010-2011 115 (60) 53 (53) NS 168 (58)
2011-2012 77 (40) 47 (47) 124 (42)
Age, y, at illness onset
Mean  SD 30.9 5.8 30.5 5.8 NS 30.7 5.8
Race/ethnicity
Hispanic 45 (23) 25 (25) NS 70 (24)
White, non-Hispanic 110 (57) 48 (48) 158 (54)
Asian, non-Hispanic 14 (7) 13 (13) 27 (9)
Other, non-Hispanic 23 (12) 14 (14) 37 (13)
Trimester at illness onset date
First (7-13 wks) 31 (16) 13 (13) NS 44 (15)
Second (14-26 wks) 85 (44) 44 (44) 129 (44)
Third (27-42 wks) 76 (40) 43 (43) 119 (41)
Recent health history, mean days  SD
For how many days during past 30 days was.
Your physical health not good? 7.1 9.7 2.0 4.9 < .001 5.2 8.6
Your mental health not good? 4.8 8.8 3.0 5.4 NS 4.1 7.7
Self-rated health status, at time of enrollment
Very good or excellent 116 (61) 68 (68) NS 184 (63)
Good 60 (31) 27 (27) 87 (30)
Fair or poor 16 (8) 5 (5) 21 (7)
High-risk comorbiditiesa
At least 1 57 (30) 17 (17) < .05 74 (25)
>1 23 (12) 2 (2) < .005 25 (9)
History of asthmab 27 (14) 2 (2) < .005 29 (10)
Obese (BMI >30 kg/m2)c 59 (31) 15 (15) < .05 74 (25)
High-risk pregnancyd 41 (21) 24 (24) NS 65 (22)
Influenza vaccination status
Current seasone 112 (58) 42 (42) < .01 154 (53)
Current season and at least 1 comorbidity 40 (21) 9 (9) < .01 49 (17)
Data are counts (column percentage), unless otherwise indicated. P values are from Pearson c2, Fisher exact test, or Student t test.
ACIP, Advisory Committee on Immunization Practices; ARI, acute respiratory illness; BMI, bodymass index; ICD-9, International Classification of Diseases, ninth revision;NS, not statistically significant.
a High-risk comorbidities, identified during 1 year prior to conception, for which influenza vaccination is recommended by the ACIP, including cancer, diabetes mellitus, neurological disorders,
chronic pulmonary disease, chronic cardiac disease, immunosuppressive disorders, chronic renal disease (codes available upon request); b Any asthma ICD-9 code (493) in the electronic medical
record within the prior year to conception; c BMI was calculated using self-reported prepregnancy weight and height; d Pregnancy complication was indicated by a medical visit associated with a
subset of ICD-9 codes related to adverse pregnancy outcomes from conception through the end of the vaccine campaign for the study year (codes available upon request); e Current season
vaccinated defined as receipt of vaccine at least 14 days prior to illness onset.
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14%; P < .005) or obesity before preg-
nancy (15% vs 31%; P < .05), and
women with inﬂuenza reported fewer
days of poor physical health in the prior
30 days (2.0 vs 7.1 days; P < .001). The
lower inﬂuenza positivity associated
with high-risk conditions and poor
health remained statistically signiﬁcant
after adjusting for the higher inﬂuenza
vaccination rate for those in poor health
(values of P < .05).
Comparisons of influenza and
noninfluenza ARI severity
Small but signiﬁcant differences in
symptom severity and illness impair-
ment were observed between inﬂuenza
and noninﬂuenza ARI. Speciﬁcally, the
median summed subjective severity of
12 symptoms was 18 for inﬂuenza ARI
vs 16 (of 36) for noninﬂuenza ARI (P <
.05; Table 2). Women with inﬂuenza
rated their illnesses as causing greater
impairment to their activities than
women with noninﬂuenza ARI (5.9 vs
4.8 on a 9 point scale; P < .001).
In terms of speciﬁc symptoms,
women with inﬂuenza were more likely
to report severe subjective feverishness
(18% vs 5%; P < .001), myalgia (28%
vs 14%, P < .005), cough (46% vs
30%, P < .01), and chills (25% vs 13%;
P < .01; Table 3). On average, women
with inﬂuenza described their cough,
nasal congestion, and fatigue as severe;
however, only cough was statistically
more severe for those with inﬂuenza
(Figure 2); myalgia, fever, and chills were
more severe among those with inﬂuenza,
but the mean severity rating for each of
these symptoms was moderate.
More women with inﬂuenza had an
elevated (37.8C) or highly elevated
(38.9C) recorded temperature (63%
and 20%, respectively) compared with
women with noninﬂuenza ARI (24%
and 5%, respectively; all P < .001
(Table 2). Illness durationwas similar for
women with inﬂuenza and noninﬂuenza
ARI (mean, 9.3 vs 10.3, respectively).
Women with inﬂuenza sought me-
dical care sooner: 53% within 2 days of
illness onset, compared with 35% among
women with noninﬂuenza ARI (P <
.001; Table 2). Slightly more women202.e5 American Journal of Obstetrics& Gynecolwith inﬂuenza reported using OTC
medications (92% vs 81%; P < .05),
but few in either group were prescribed
or used antibiotic or antiviral medica-
tions. In fact, few women with inﬂuenza
were prescribed antiviral medications
(8%), and there was no difference in the
likelihood of either group to be prescribed
antibiotic medications (11% vs 16%).
In multivariate analyses adjusting
for site, season, age, vaccination status,
and days since illness onset, several var-
iables showed signiﬁcant differences be-
tween inﬂuenza and noninﬂuenza ARI
(Table 4). The adjusted odds of having
a temperature greater than 38.9C or
severe subjective feverishness was greater
than 4-fold higher among women with
inﬂuenza. The adjusted odds were 2
times higher for activity impairment,
early care-seeking behavior, a higher 12
symptom severity score, severe subjec-
tive cough, and chills.
Impact of vaccination status,
comorbidities, and trimester on
influenza illness severity
Among 100 women with inﬂuenza ill-
nesses, illness severity did not differ by
trimester, receipt of inﬂuenza vaccine, or
the presence of comorbidities (Supple-
mental Table). Within the same group, a
temperature of 38.9C or greater was
more common among those vaccinated
vs unvaccinated (40% vs 17%, P < .01),
but the severity of subjective symptoms
did not differ among those vaccinated vs
unvaccinated (data not shown).
Secondary analyses
Despite the small number of inﬂuenza
cases by inﬂuenza (sub)type, we con-
ducted exploratory analyses to compare
severity indicators by inﬂuenza type and
subtype. The mean symptom severity
score was higher for inﬂuenza B illnesses
than either inﬂuenza A(H3N2) (19.7
vs 17.4, P < .05) or inﬂuenza A(H1N1)
pdm09 (19.7 vs 17.2, P < .05; Figure 3).
There were no signiﬁcant differences in
illness duration (means, 9.4 days for
inﬂuenza B, 8.0 for A[H3N2], and 8.5
for A[H1N1]pmd09 virus infections).
In a sensitivity analysis, we limited
participants to those with illness onset
of 4 days or less from the home visitogy FEBRUARY 2015and respiratory specimen collection and
noted no difference in the direction or
pattern of effects. We also excluded
nonemedically attended illnesses and
found it also did not change the main
ﬁndings.
COMMENT
We found that pregnant women
with inﬂuenza illnesses described some
symptoms as more severe (especially
cough, myalgia, fever, and chills), re-
ported greater subjective impairment,
and were more likely to seek care earlier
and to have highly elevated tempera-
tures. Among the women infected with
inﬂuenza, inﬂuenza vaccination was not
associated with less severe illness.
We found a median symptom severity
score of 18 (of 36) for inﬂuenza illnesses
in pregnant women, which was with-
in the range that Belongia et al10 re-
ported using for the same measure for
nonhospitalized adults infected with 3
different inﬂuenza A strains, using the
same scale. Women with inﬂuenza were
more likely to seek medical care within
2 days of onset, which suggests that se-
vere symptoms present more rapidly
after onset. More than half of episodes
(53%) were associated with an medical
encounter within the ﬁrst 2 days of
onset, similar to previously reported
estimates of 45-60% for inﬂuenza A
among community-dwelling adults and
children.12 Women with inﬂuenza rated
the impairment caused by their illness as
greater than those with noninﬂuenza
ARI, similar to a recent study with
health care workers using the same
measures.11
This study has several strengths. We
directly compared the epidemiological
and clinical characteristics of inﬂuenza
and noninﬂuenza ARI in the same pop-
ulation of pregnant women using iden-
tical enrollment, laboratory diagnostics,
and follow-up methods. We used EMRs
to conduct surveillance to identify
women eligible for testing and to deter-
mine vaccination status and comorbid-
ities, thereby reducing recall biases, and
we used RT-PCR testing, collection of
detailed data regarding clinical and
subjective manifestations of illness, and
quick response time between illness
TABLE 2
Clinical characteristics associated with influenza vs noninfluenza ARIs among pregnant women
Characteristics
Noninfluenza ARI
(n[ 192) Influenza (n[ 100) P value
Illness and specimen collection timing
Days from onset to swab, mean days  SD 4.7 1.8 4.2 2.0 < .05
Subjective symptom severity and impact
12-symptom severity score, median/IQR a 16 12-20 18 14-20 < .05
Overall subjective severity, mean score  SD b 4.7 1.8 4.3 2.0 NS
Subjective impairment, mean score  SDc 4.8 2.3 5.9 1.9 < .001
Illness duration, mean days  SDd 10.3 4.8 9.3 4.2 NS
Fever severity
Any fever, 37.8C 47 (24) 63 (63) < .001
Highly elevated fever of 38.9C 9 (5) 20 (20) < .001
Highest recorded temperature, mean C  SD 37.2 0.8 38.0 1.0 < .001
Medical utilization during illness
Any medical visit for ARIe 156 (81) 88 (88) NS
Two or more medical visits for ARI 76 (40) 42 (42) NS
Early care-seeking behaviorf 68 (35) 53 (53) < .001
First medical encounter, mean days  SDg 3.0 2.1 2.4 2.2 < .05
Emergency department visits 15 (8) 12 (12) NS
Illness-associated hospitalization 7 (4) 5 (4) NS
Use of medications
Antibiotic prescription
Prescribed 30 (16) 11 (11) NS
Self-reported use 21 (11) 9 (9) NS
Antiviral prescription
Prescribed 2 (1) 8 (8) NS
Self-reported use 6 (3) 10 (10) NS
OTC medications, self-reported use 155 (81) 92 (92) < .05
Data are counts (column percentage), unless otherwise indicated. P values are from Pearson c2, Fisher exact, or Student t tests.
ARI, acute respiratory illness; ICD-9, International Classification of Diseases, ninth revision; IQR, interquartile range; NS, not statistically significant; OTC, over-the-counter medications.
a Summed subjective severity of 12 symptoms: cough, fatigue, feverishness, congestion, headache, myalgia, sore throat, chills, wheezing, ear pain, nausea, and vomiting. Each symptom was rated
as absent (0), mild (1), moderate (2), or severe (3), except for cough, which did not have a response option (0); b Participants were asked to rate their health during their illness (0, normal health; 9,
worse possible health); c Participants were asked to rate their ability to perform activities during their illness (0, able to perform usual activities; 9, unable to perform usual activities; severe
was defined as an impairment rate of6); d Mean illness duration was calculated using only the response from those participants who could recall the date their illness ended (noninfluenza ARI
[n¼ 139] and influenza [n¼ 75]); e Medically attended acute respiratory illness visits that occurred between onset and recovery date with at least 1 of these ICD-9 codes: 460-466, 480-488 or
490-491; f Medically attended 2 days or less following onset; g Days between illness onset and first medical visit (includes only those people who had medical encounters).
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interviewing participants about their
illness.
Our study also has several limitations.
The highest fever reached during the
illness was an important measure of
severity; however, we had to rely on thehighest reported temperature, which
may understate the true severity of
fever if women are not consistently
and repeatedly taking their tempera-
ture. We were also unable to determine
the duration of fever. Our focus on
febrile ARI with cough preventedFEBRUARY 2015 Amerius from considering mild or atypical
manifestations of inﬂuenza illness. A
report of 2 seasonsmay reﬂect the clinical
manifestations of circulating inﬂuenza
viruses during those seasons and may
not be generalizable to other strains or
seasons. The small number of inﬂuenzacan Journal of Obstetrics& Gynecology 202.e6
TABLE 3
Self-reported symptom severity measures associated with influenza vs
noninfluenza ARIs among pregnant women
Characteristics
Percentage self-reported as severe
Noninfluenza
ARI (n[ 192)
Influenza
(n[ 100) P value
Upper respiratory symptoms
Nasal congestion 90 (47) 42 (42) NS
Sore throat 65 (34) 23 (23) NS
Ear pain 17 (9) 11 (11) NS
Lower respiratory symptoms
Cougha 57 (30) 46 (46) < .01
Wheezing 11 (6) 4 (4) NS
Systemic symptoms
Fatigue 66 (34) 41 (41) NS
Myalgia 26 (14) 28 (28) < .005
Feverishness 9 (5) 18 (18) < .001
Chills 25 (13) 25 (25) < .01
Headache 48 (25) 18 (18) NS
Gastrointestinal symptoms
Vomiting 15 (8) 5 (5) NS
Nausea 18 (9) 5 (5) NS
Data are counts (column percentage), unless otherwise indicated. P values are from Pearson c2, Fisher exact, or Student t
tests.
ARI, acute respiratory illness; NS, not statistically significant.
a Ten participants reported cough as absent during their illness: in these instances, their responses were recoded as 1 (mild)
because a cough was present at the time they were deemed eligible to participate in the study.
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Research Obstetrics ajog.orgillnesses available for analysis limited our
power to examine differences among
inﬂuenza (sub)types, vaccination status,
trimester at onset, or more serious illness
outcomes (eg, hospitalization). We were
unable to disentangle the contributions
of host, agent, and environment in
inﬂuencing the risk of infection or
manifestations of disease.
With a larger sample size, it would be
useful to explore whether a combination
of symptoms and severity could effec-
tively rule in or rule out inﬂuenza prior
to receiving test results. The relatively
small number of inﬂuenza and non-
inﬂuenza illnesses examined in this
study limited the precision of our ﬁnd-
ings; future studies with more precise
estimates of the positive and negative202.e7 American Journal of Obstetrics& Gynecolpredictive value of illness symptomsmay
facilitate potential clinical applications.13
Medication usage could have affect-
ed severity and clinical outcomes. Use of
antiviral and antibiotics was similar
across groups; however, more inﬂuenza-
positive women took OTC medications,
which could have masked severity. Some
self-reported data (eg, symptom severity,
use of OTCmedications, smoking status,
and self-reported vaccine status for the
14 women vaccinated outside the Kaiser
Permanente system [5%]) could not be
veriﬁed.
Comparisons of influenza and
noninfluenza ARI severity
This study indicates that inﬂuenza and
noninﬂuenza ARIs in pregnant womenogy FEBRUARY 2015are distinguishable based on subjective
and EMR-based severity measurements.
These differences persisted after ad-
justing for site, season, age, vaccination
status, and days since illness onset. Our
logistic regression analyses revealed a
strong association between an inﬂuenza-
positive illness and severe cough and/or
fever. Overall, our ﬁndings generally are
consistent with prior studies of inﬂuenza
illnesses.10-12
Although most inﬂuenza and non-
inﬂuenza ARI illnesses involved fever,
feverishness, or chills, records of highly
elevated temperature (>38.9C) were
much more common among inﬂuenza
(20% vs 5% noninﬂuenza ARI). High
fever is a cause for concern because a
temperature elevation of 1.9C over
normal (37.0C) is the threshold for
assessing teratogenic risk (eg, neural
tube defects).14,15 There is little infor-
mation on the effects of higher temper-
ature elevations for short exposures or
more modest elevations for longer pe-
riods of time, although both situations
can yield a similar thermal dose (ie,
length and intensity of fever). We were
unable to measure fever duration; how-
ever, 20% of inﬂuenza illnesses reached
the temperature risk threshold. After
adjusting for site, season, age, vaccina-
tion status, and days since illness on-
set, we found the odds of reaching or
exceeding this risk threshold were
greater than 4.5-fold higher among
inﬂuenza-positive women.
Although antiviral medications may
reduce complications of inﬂuenza illness
and shorten symptom duration,16-18
few women in our study with inﬂuen-
za illnesses (10%) were prescribed anti-
virals; this is a somewhat lower rate
of use than was reported previously
(15-22%) for nonpregnant adults.10,12
The reasons for this relatively low
level of antiviral use probably include
the fact that only 36% of women in our
study sought medical care within 2 days
after illness onset and within the ideal
window for antiviral treatment. The
lower use of antiviral medications in
some integrated care systems19 and
the hesitancy of pregnant women to
take medications in general20 may have
also contributed.
FIGURE 2
Mean response to self-reported severity ranking of 12 symptoms
Mean response to self-reported severity ranking of 12 symptoms, with 95% confidence intervals.
Symptoms are sorted by mean severity score: severe,2; moderate, 1e1.9; mild,>1. Vertical line
with solid circle indicates influenza illnesses; vertical line with open circle indicates noninfluenza ARI.
Asterisk indicates symptoms with statistically different responses between influenza and non-
influenza ARI (P < .01).
ARI, acute respiratory illness.
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TABLE 4
Results of logistic regression of factors associated with influenza vs
noninfluenza acute respiratory illnesses among 292 pregnant women,
2 sites, 2010-2012
Characteristics aOR [95% CI]a P value
Site (referent, KPNC) 1.66 [0.98e2.82] .062
Season (referent, 2010-2011) 0.76 [0.45e1.27] .288
Age at illness onset (referent, <31 y) 0.78 [0.48e1.27] .317
Vaccination status in current season (referent,
unvaccinated)
0.58 [0.35e0.96] .034
Influenza test 6 days or longer after onset
(referent, <6 d)
0.75 [0.44e1.28] .289
Highest recorded temperature 38.9C (referent,
<38.9C)
4.51 [1.92e10.56] < .0001
Activities greatly impaired (referent, not greatly
impaired)
2.43 [1.42e4.18] .001
Early care-seeking behavior (referent,
visit >2 d after onset)
2.28 [1.36e3.82] .002
12 symptom severity score (referent, not severe) 2.06 [1.10e3.87] .025
Subjective feverishness severe
(referent, not severe)
4.08 [1.71e9.70] .002
Subjective cough severe (referent, not severe) 2.05 [1.21e3.46] .007
Subjective chills severe (referent, not severe) 2.01 [1.06e3.80] .032
aOR, adjusted odds ratio; CI, confidence interval; KPNC, Kaiser Permanente Northern California.
a Adjusted for site, season, age, vaccination status, and days from illness onset to influenza testing.
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FIGURE 3
Mean sum of 12 self-reported
symptoms by influenza virus
type/subtype
Mean sum of 12 self-reported symptoms by
influenza virus type/subtype compared with
noninfluenza illnesses, with 95% confidence in-
tervals shown. Individual summed scores ranged
from 6 to 29. One case with an unsubtypable
influenza illness has been excluded from this
figure. Mean severity scores for influenza B and
noninfluenza are statistically different. Symp-
toms include cough, fatigue, feverishness,
congestion, headache, myalgia, sore throat,
chills, wheezing, ear pain, nausea, and vomiting.
Each symptom was rated as absent (0), mild (1),
moderate (2), or severe (3), except for cough,
which did not have a mild response option.
Sokolow. Inﬂuenza severity in pregnant women. Am J Obstet
Gynecol 2015.
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FEBRUARY 2015 AmeriImpact of trimester and vaccination
status on influenza illness severity
We found no evidence that inﬂuenza
vaccination was associated with lower
subjective symptom severity. Vaccinated
women were more likely to have a high
fever of 38.9C or greater (40% vs
17%; P < .01); we cannot explain this
ﬁnding. Power for analyzing the impact
of vaccination on other illness severity
characteristics was low because of the
small number of inﬂuenza illnesses
when separated by vaccination status
(42 vaccinated and 58 unvaccinated).
Patients were diagnosed in all tri-
mesters of pregnancy, and we found little
evidence that inﬂuenza illnesses in third-
trimester pregnant women were more
severe than those that occurred earlier.
Women with third-trimester illnesses
did have fewer severe nausea symptoms,
but it is difﬁcult to differentiate typical
early pregnancy nausea from nausea
caused by inﬂuenza.can Journal of Obstetrics& Gynecology 202.e8
Research Obstetrics ajog.orgImpact of influenza type/subtype on
illness severity
Women infected with inﬂuenza B viruses
were more likely to have severe symp-
toms than either inﬂuenza A subtype
(mean severity score, 19.7 vs 17.4 for
inﬂuenza A[H3N2] and 17.2 for inﬂu-
enza A[H1N1]pdm09). Although the
severity of inﬂuenza B virus infections
among adults is debated,21 this ﬁnding
differs from some published studies.
For example, Irving et al12 found that
over 4 seasons in 2007e2011, inﬂuenza
B illnesses were milder than inﬂuenza A.
The discrepancy could reﬂect seasonal
variation in the virulence of inﬂuenza B
viruses.21Conclusion
Inﬂuenza had a greater negative impact
on pregnant women than noninﬂuenza
ARIs. This ﬁnding adds to a growing
literature indicating that illness caused
by inﬂuenza virus infection, even among
those not requiring hospitalization, is
moderately more severe than illnesses
caused by other respiratory pathogens
and reinforces the importance of inﬂu-
enza prevention and control efforts
among pregnant women and women
planning to become pregnant in the next
12 months.9 -
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Pregnant women with febrile acute respiratory illness
Number of pregnant women with febrile acute respiratory illness (ARI) who tested positive or negative
for influenza by week of testing during 2010-2011 and 2011-2012 seasons.
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SUPPLEMENTAL TABLE
The influence of selected factors on self-reported symptom severity measures among 100 pregnant women with
laboratory-confirmed influenza during 2010-2012 influenza season, 2 sites
Severity
Illness severitya
Total
(n[ 100)
Mild or moderate
(n[ 54) Severe (n[ 26) P value
Trimester at illness onset
First or second trimester 42 (74) 15 (26) NS 57 (100)
Third trimester 32 (74) 11 (26) 43 (100)
Current season vaccination statusb
Vaccinated 43 (74) 15 (26) NS 58 (100)
Not vaccinated 31 (74) 11 (26) 42 (100)
Comorbidities
None 60 (72) 23 (28) NS 83 (100)
One or more 14 (82) 3 (18) 17 (100)
Data are counts (row percentage). P values are from Pearson c2 or Fisher exact test.
NS, not statistically significant.
a Summed subjective severity of 12 symptoms were defined as severe if score was 22-29; b Current-season vaccination status defined as receipt of vaccine at least 14 days prior to illness onset.
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